Oncology Central

Discussion with Professor Argiris on the continuum of care in recurrent/metastatic head and neck cancer


In this video interview, Professor Athanassios Argiris – Medical Oncologist from Hygeia Hospital (Athens, Greece) – discusses the current landscape of treatment for recurrent/metastatic head and neck cancer, highlighting the role of targeted therapies (cetuximab) and emerging immunotherapy agents (nivolumab).




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.